Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2546783 | 0.86 | GPR3 (0.41) | MEN1KMT2A | |
| SCHEMBL23211689 | 0.69 | GPR3 (0.41) | MEN1KMT2A | |
| SCHEMBL22402769 | 0.69 | GPR3 (0.35) | MEN1GAAKMT2ATSHR | |
| SCHEMBL31021487 | 0.69 | GPR3 (0.35) | MEN1GAAKMT2ATSHR | |
| SCHEMBL2480013 | 0.66 | GPR3 (0.43) | MEN1KMT2A | |
| SCHEMBL7056977 | 0.66 | GPR3 (0.43) | MEN1KMT2A | |
| SCHEMBL29596197 | 0.66 | GPR3 (0.43) | MEN1KMT2A | |
| SCHEMBL7048563 | 0.66 | GPR3 (0.43) | MEN1KMT2A | |
| SCHEMBL29407826 | 0.62 | S100A4 (0.43) | MEN1GAAKMT2ALMNATSHR | |
| SCHEMBL2727777 | 0.61 | HTR2A (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6740766-B2 | USING SMALL AMOUNT OF QUATERNARY ORGANOPHOSPHONIUM SALT; EASILY RECOVERED FOR RECYCLE; HIGH CATALYTIC ACTIVITY EVEN AT LOW TEMPERATURE; LOW COST | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-05-25 | — | — | US | disclosed |
| US-20040063983-A1 | PREPARATION OF ORGANOCHLOROSILANES BY THE SILYLATION OF CONJUGATED DIENES WITH TRICHLOROSILANE | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063983-A1 | PREPARATION OF ORGANOCHLOROSILANES BY THE SILYLATION OF CONJUGATED DIENES WITH TRICHLOROSILANE | CDC5L, DCLK1, CCRL2 | MEN1 926/4885GAA 4657/4885KMT2A 2715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.